Japanese Pharmaceutical Organization Selects Instem’s Preclinical Software Solution Suite

Leading Japanese Pharmaceutical Company Chooses Provantis® Preclinical Software Solution for Osaka Facility

CONSHOHOCKEN, Pa.--()--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that one of Japan’s leading research-oriented global pharmaceutical companies has purchased the Provantis preclinical software solution for their Osaka R&D facility, following a competitive evaluation.

Headquartered in Tokyo, this global organization focuses its development efforts in the fields of urology, immunology and infectious diseases, oncology, neuroscience, and DM complications and metabolic diseases.

Key facts

  • Comprehensive suite of modules purchased to support the areas of General Toxicology, Reproductive Toxicology, Pathology and Pharmacy
  • Competitive evaluation conducted; Instem selected for best product fit combined with global market leadership
  • Replacing an ageing legacy solution, the project also includes a systems integration component, leveraging the client’s investment in existing software systems and demonstrating a commitment to an “open” systems approach

Instem will be working in close co-operation with their Japanese distributor, CTCLS, to ensure a smooth and successful deployment. CTCLS is one of Japan’s leading providers of integrated R&D support systems for the life sciences, supporting Instem’s solutions through their full service offices in Tokyo and Osaka.

Neil Donaldson, VP of European & Asian Operations, Instem said, “This is excellent news for both CTCLS and Instem, and demonstrates the winning combination of global technology leadership and local support that we offer to organizations throughout Japan.”

As a member of Itochu Techno-Solutions Corporation, CTCLS has evolved into one of Japan's leading solution providers, specializing in the integration of R&D support systems for life science companies.

With incomparable end-to-end solution capability, CTCLS deals with pharmaceutical, chemical and food manufacturers, as well as universities and public offices, and offers a wide-range of products and services that cover every stage of R&D activities.

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making.

Instem’s pre-clinical study management solutions accelerate drug and chemical development by increasing productivity, automating processes and enhancing practices that lead to safer and more effective healthcare products. Instem’s powerful bioinformatics solutions support translational science initiatives by accelerating access to scientific information for better decision support during product discovery, development and commercialization.

Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com.

Do more. Go further™.


Gary Mitchell, 610-941-0990

Release Summary

Japanese Pharma Purchases Instem Preclinical Software


Gary Mitchell, 610-941-0990